Coenzyme Q10 Supplementation in Clinical Medicine
Coenzyme Q10 supplementary therapy in patients is based on its antioxidant and reenergization effects. CoQ10 has been successfully used in clinical medicine as a supplementary therapy in several diseases: in patients with mitochondrial neuromuscular diseases, neurodegenerative diseases (Parkinson’s, dementias), cardiovascular diseases (congestive heart failure, cardiomyopathy), statins therapy, chronic fatique syndrom, nephropathy, cancer –breast treatment, chemotheraphy amelioration, diabetes mellitus, bronchial asthma, infertile men, sports medicine, stress and ageing. Bioavailability, dosage and duration of CoQ10 treatment are important factors for human tissue uptake and beneficial effect of administered CoQ10.
KeywordsDiabetic Neuropathy Lipoic Acid Diabetic Peripheral Neuropathy Diabetic Cardiomyopathy Thioctic Acid
Unable to display preview. Download preview PDF.
- 1.Gvozdjáková A, Kucharská J, Hlavatá A, Braunová Z, Reichrtová E, Kajglová A, Kapellerová A (2000) Effect of coenzyme Q10 in children with metabolic diseases. J Am Coll Nutr 19(5): Abstract 117, p 704. The American College of Nutrition’s 41st Annual Meeting, Las Vegas, USA, 12–15 October 2000 (Prize award)Google Scholar
- 1.Gazdíková K, Gvozdjáková A, Kucharská J, Spustová V, Braunová Z, Dzúrik R (2000) Malondialdehyde and selected antioxidant plasma levels in conservatively treated patients with kidney diseases. BMJ 101:490–494Google Scholar
- 4.Gvozdjáková A (2000) Coenzyme Q10 (experimental study). Effects of hydrosoluble, liposoluble and reduced coenzyme Q10 forms in aged rats. Tishcon Corp. USA: Project, 2000, Part 6, Kidney Mitochondria: P6/4–P17 tables and figuresGoogle Scholar
- 5.Gvozdjáková A, Gazdíková K, Kucharská J, Spustová V, Braunová Z, Dzúrik R (2000) The effect of coenzyme Q10 in patients with nephropathies. J Am Coll Nutr 19(5):708. American College of Nutrition, 41st Annual Meeting, Las Vegas, 12–15 October 2000, Abstract 132Google Scholar
- 6.Gvozdjáková A., Gazdíková K, Kucharská J, Spustová V, Braunová Z, Dzúrik R (2000) Deficit of coenzyme Q10 in patients with nephropathies and beneficial effect of supplementary therapy with coenzyme Q10. The Second Conference of the International Coenzyme Q 10 Association, Frankfurt, Germany, 2000, December 1–4, abstract book pp 111–112Google Scholar
- 2.Gvozdjáková A, Kucharská J, Bartkovjaková M, Gazdíková K, Gazdík F (2005a) Coenzyme Q10 supplementation reduces corticosteroid dosage in patients with asthma bronchiale. Fourth Conference of the International Coenzyme Q 10 Association, Los Angeles, 2005, Abstract book pp 108–109Google Scholar
- 4.Gvozdjáková A (2006) Asthma, corticosteroids and coenzyme Q10. http://www.vitasearch.com/get/PC/experts/AGvozdjakovaAT10–02-06.htm
- 1.Cadenas E, Packer L (1996) (eds) Handbook of Antioxidants. Marcel Dekker, NY, pp 545–591Google Scholar
- 3.Gvozdjáková A, Palacka P, Kucharská J, Okkelová A, Murín J (2007) Beneficial effect of simultaneous coenzyme Q10 and -lipoic acid supplementation in patients with diabetic cardiomyopathy. Fifth Conference of the International Coenzyme Q 10 Association, Kobe, Japan, November 9–12, 2007, No. JP-051Google Scholar
- 4.Murray MT (1996) Encyclopedia of Nutritional Supplements. Prima Publishing, Rocklin, CA, pp 243–346Google Scholar